Filters
Standstill in the approval process for CBD products as novel foods
What is new on preliminary injunction proceedings in pharma and biotech cases in Germany – and would it be different under the UPC?
Pharma cases: No proportionality defence without (expedited) request for compulsory license
Update on compulsory licensing in the context of COVID-19 – public consultation of the EU commission
Taylor Wessing advises General Catalyst on Series B financing round in Localyze
Asserting dependent claims in German patent infringement proceedings
Yuga Labs v Ryder Ripps - Franco-German cross-analysis of the copyright aspects of the case
Possibilities of special permissions for medical devices on national markets
EU Health Technology Assessment (HTA) Regulation (2021/2282) of January 11, 2022.
Background: History of the HTA Regulation
